Case Report

Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria

Volume: 10 Number: 04 December 15, 2020
  • Selma Bouheraoua
  • Farida Assaous
  • Nora Zourdani
  • Naima Tahrat
  • Hassiba Tali Maamar
EN

Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria

Abstract

We describe the emergence of plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19. The strain was isolated from a urine sample of a 75-year-old male patient. The identification was carried out by an automated system. The antibiogram was performed according to CLSI recommendations. The colistin MIC was determined by broth micro-dilution according to CA-SFM/EUCAST criteria. The detection of mcr-1 was carried out by immunochromatographic test and PCR mcr-1. Genetic transfers and determination of the plasmid incompatibility group were made. The ST was carried out by MLST using the Pasteur scheme. The strain has a high-level penicillinase resistance phenotype. It was susceptible to amikacin and resistant to gentamicin, tobramycin, fluoroquinolones, tetracycline, chloramphenicol, and cotrimoxazole. The strain was resistant to colistin (MIC ꞊ 4 μg/ml). The genetic transfer is given a colistin-resistant transconjugant. The plasmid carrying mcr-1 gene belongs to the incompatibility group IncHI2.The strain belongs to ST19. J Microbiol Infect Dis 2019; 10(4):222-224.

Keywords

References

  1. 1. Liu Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases. févr 2016;16(2):161‑8.
  2. 2. Dortet L, Bonnin R, Jousset A, Gauthier L, Naas T. Émergence de la résistance à la colistine chez les entérobactéries : une brèche dans le dernier rempart contre la pan-résistance ! Journal des Anti-infectieux. déc 2016;18(4):139‑59.
  3. 3. CLSI. Performance standards for Antimicrobial Susceptibility testing. 28th ed. CLSI supplement M100.Wayne, PA: Clinical and Laboratory Standard Institute; 2018. (ISBN: 1-56238-839-8)
  4. 4. Enterobacteriaceae. In: CASFM / EUCAST: Société Française de Microbiologie Ed; 2018: p.36-43.
  5. 5. Chabou S, Leangapichart T, Okdah L, Le Page S, Hadjadj L, Rolain J-M. Real-time quantitative PCR assay with Taqman ® probe for rapid detection of MCR-1 plasmid-mediated colistin resistance. N Microb N Infect 2016; 13:71‑4.
  6. 6. Jaureguy F, Landraud L, Passet V, et al. Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics 2008;9 (1):560.
  7. 7. Bachiri T, Lalaoui R, Bakour S, et al. First Report of the Plasmid-Mediated Colistin Resistance Gene mcr-1 in Escherichia coli ST405 Isolated from Wildlife in Bejaia, Algeria. Microbial Drug Resist 2018; 24(7):890‑5.
  8. 8. Yanat B, Machuca J, Yahia RD, Touati A, Pascual Á, Rodríguez-Martínez J-M. First report of the plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in Algeria. Intern J Antimicrob Agent 2016;48(6):760‑1.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Case Report

Authors

Selma Bouheraoua This is me
Algeria

Farida Assaous This is me
Algeria

Nora Zourdani This is me
Algeria

Naima Tahrat This is me
Algeria

Hassiba Tali Maamar This is me
Algeria

Publication Date

December 15, 2020

Submission Date

December 22, 2020

Acceptance Date

August 23, 2020

Published in Issue

Year 2020 Volume: 10 Number: 04

APA
Bouheraoua, S., Assaous, F., Zourdani, N., Tahrat, N., & Maamar, H. T. (2020). Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases, 10(04), 222-224. https://doi.org/10.5799/jmid.839476
AMA
1.Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. J Microbil Infect Dis. 2020;10(04):222-224. doi:10.5799/jmid.839476
Chicago
Bouheraoua, Selma, Farida Assaous, Nora Zourdani, Naima Tahrat, and Hassiba Tali Maamar. 2020. “Plasmid-Mediated Colistin Resistance Mcr-1 in a Clinical Isolate of Escherichia Coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases 10 (04): 222-24. https://doi.org/10.5799/jmid.839476.
EndNote
Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT (December 1, 2020) Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. Journal of Microbiology and Infectious Diseases 10 04 222–224.
IEEE
[1]S. Bouheraoua, F. Assaous, N. Zourdani, N. Tahrat, and H. T. Maamar, “Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria”, J Microbil Infect Dis, vol. 10, no. 04, pp. 222–224, Dec. 2020, doi: 10.5799/jmid.839476.
ISNAD
Bouheraoua, Selma - Assaous, Farida - Zourdani, Nora - Tahrat, Naima - Maamar, Hassiba Tali. “Plasmid-Mediated Colistin Resistance Mcr-1 in a Clinical Isolate of Escherichia Coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases 10/04 (December 1, 2020): 222-224. https://doi.org/10.5799/jmid.839476.
JAMA
1.Bouheraoua S, Assaous F, Zourdani N, Tahrat N, Maamar HT. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. J Microbil Infect Dis. 2020;10:222–224.
MLA
Bouheraoua, Selma, et al. “Plasmid-Mediated Colistin Resistance Mcr-1 in a Clinical Isolate of Escherichia Coli ST19 in Algeria”. Journal of Microbiology and Infectious Diseases, vol. 10, no. 04, Dec. 2020, pp. 222-4, doi:10.5799/jmid.839476.
Vancouver
1.Selma Bouheraoua, Farida Assaous, Nora Zourdani, Naima Tahrat, Hassiba Tali Maamar. Plasmid-mediated colistin resistance mcr-1 in a clinical isolate of Escherichia coli ST19 in Algeria. J Microbil Infect Dis. 2020 Dec. 1;10(04):222-4. doi:10.5799/jmid.839476